Prevalence of cognitive disorders differs as a function of age in HIV virus infection

AIDS

Volumn 18, Issue SUPPL. 1, 2004, Pages

  Becker, James T ^a,b   Lopez, Oscar L ^a   Dew, Mary Amanda ^a   Aizenstein, Howard J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Neuropsychological Research Program   (United States)

Author keywords

Aging; AIDS; Dementia; Mild cognitive impairment; Neuropsychology

Indexed keywords

ALCOHOL;

ACADEMIC ACHIEVEMENT; ADULT; AGE DISTRIBUTION; ALCOHOL ABUSE; ALCOHOLISM; COGNITIVE DEFECT; COMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; DEMENTIA; DISEASE CLASSIFICATION; DISEASE SEVERITY; EVALUATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HEALTH VISITOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; NEUROPSYCHIATRY; PATIENT REFERRAL; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RISK; RISK FACTOR; SAMPLING; SEROLOGY; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; VIRUS LOAD; VOLUNTEER;

EID: 1642318439     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200418001-00003     Document Type: Conference Paper

References (44)

1. Wenger JD, Whalen CC, Lederman MM. Prognostic factors in acquired immunodeficiency syndrome. J Gen Intern Med 1988, 3:464-470.
2. Justice AC, Landefeld S, Asch SM, Gilford A, Whalen C, Covinsky K. Justification for a new cohort study of people aging with and without HIV infection. J Clin Epidemiol 2001, 54:S3-S8.
3. Justice AC, Whalen CC. Aging and AIDS. J Gen Intern Med 1996, 11:645-647.
4. Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 1992, 42:1472-1476.
5. Chiesi A, Vella S, Dally LG, Pedersen C, Danner S, Johnson AM, et al. Epidemiology of AIDS dementia complex in Europe. J Acquired Immune Defic Syndr 1996, 11:39-44.
6. Hinkin CH, Castellon SA, Atkinson JH, Goodkin K. Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol 2001, 54 (Suppl. 1):S44-S52.
7. Goodkin K, Wilke FL, Concha M, Hinkin CH, Symes S, Baldewicz TT, et al. Aging and neuro-AIDS conditions and the changing spectrum of HIV1-associated morbidity and mortality. J Clin Epidemiol 2001, 54 (12 Suppl. 1):S35-S43.
8. American Academy of Neurology. Nomenclature and research case definitions for the neurological manifestations of human immunodeficiency virus type-1 infection. Neurology 1991, 41:778-785.
9. Van Gorp WG, Miller EN, Marcotte TD, Dixon W, Paz D, Selnes O, et al. The relationship between age and cognitive impairment in HIV-1 infection: findings from the Multicenter AIDS Cohort Study and a clinical cohort. Neurology 1994, 44:929-935.
10. Becker JT, Sanchez J, Dew MA, Lopez OL, Dorst SK, Banks G. Neuropsychological abnormalities among HIV-infected individuals in a community-based sample. Neuropsychology 1997, 11:592-601.
11. Dew MA, Becker JT, Sanchez J, Caldararo R, Lopez OL, Giconi J, et al. Prevalence and predictors of depressive, anxiety, and substance use disorders in HIV-infected and -uninfected men: a longitudinal evaluation. Psychol Med 1997, 27:395-409.
12. Lopez OL, Wess J, Sanchez J, Dew MA, Becker JT. Neurological characteristics of HIV-infected men and women seeking primary medical care. Eur J Neurol 1999, 6:1-5.
13. Ganguli M, Dodge HH, Chen P, Belle S, DeKosky ST. Ten-year incidence of dementia in a rural elderly US community population. Neurology 2000, 54:1109-1116.
14. Becker JT, Huff FJ, Nebes RD, Holland A, Boller F. Neuropsychological functioning in Alzheimer's disease: pattern of impairment and rates of progression. Arch Neurol 1988, 45:263-268.
15. Huff FJ, Becker JT, Belle S, Nebes RD, Holland AL, Boller F. Cognitive deficits and clinical diagnosis of Alzheimer's. Neurology 1987, 37:1119-1124.
16. American Psychiatric Association. DSM-IV: Diagnostic and Statistic Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
17. Bridge TP. AIDS and HIV CNS disease: a neuropsychiatric disorder. Adv Biochem Psychopharmacol 1988, 44:1-13.
18. Hardy DJ, Hinkin CH, Satz P, Stenquist PK, van Gorp WG, Moore LH. Age differences and neurocognitive performance in HIV-infected adults. NZ J Psychol 1999, 28:94-101.
19. Wilkie F, Dickinson G, Symes S, Goodkin K, Czaja S, Feaster D, et al. The cognitive effects of HIV1-infection in elderly men. The Gerontologist 1995, 56:125-126.
20. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999, 56:303-308.
21. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001, 58:397-405.
22. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study, Part 1. Arch Neurol 2003, 60:1385-1389.
23. Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, et al. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study, Part 2. Arch Neurol 2003, 60:1394-1399.
24. Bell-McGinty S, Butters MA, Meltzer CC, Greer PJ, Reynolds CF, Becker JT. Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry 2002, 159:1424-1427.
25. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 1996, 93:3908-3913.
26. Kilbourne AM, Justice AC, Rabeneck L, Rodriguez-Barradas M, Weissman S. General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era. J Clin Epidemiol 2001, 54 (Suppl. 1):S22-S28.
27. Aisen PS, Davis KL. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry 1994, 151: 1105-1113.
28. McGeer PL, Rogers J, McGeer EG. Neuroimmune mechanisms in Alzheimer's disease patients. Alzheimer Dis Assoc Disord 1994, 8:149-158.
29. Rogers J, Luber-Narod J, Styren SD, Civin WH. Expression of immune system associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol Aging 1988, 9:339-349.
30. Perlmutter LS, Scott SA, Barron E, Chui HC. MHC class II-positive microglia in human brain: association with Alzheimer lesions. J Neurosci Res 1992, 33:549-558.
31. Minagar M, Shapshak P, Fujimiura R, Ownby R, Heyes M, Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neural Sci 2002, 202:13-23.
32. Mankowski JL, Queen SE, Tarwater PM, Fox KJ, Perry VH. Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol 2002, 61:85-90.
33. Izycka-Swieszewska E, Zoltowska A, Rzepko R, Gross M, Borowska-Lehman J. Vasculopathy and amyloid beta reactivity in brains of patients with acquired immune deficiency (AIDS). Folia Neuropathol 2000, 38:175-182.
34. Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. Infect Dis 2002, 186:1023-1027.
35. Holmberg SD, Moorman AC, Williamson JM, Tong TC, Ward DJ, Wood KC, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 2002, 360:1747-1748.
36. Barbaro G, Lipshultz SE. Pathogenesis of HIV-associated cardiomyopathy (HIV-associated cardiovascular disease: clinical and biological insights: part II. Pathogenesis and molecular biology). Ann NY Acad Sci 2001, 946:57-81.
37. Antinori A, Giancola ML, Alba L, Soldani F, Grisetti S. Cardiomyopathy and encephalopathy in AIDS (HIV-associated cardiovascular disease: clinical and biological insights: part II. Pathogenesis and molecular biology). Ann NY Acad Sci 2001, 946:121-129.
38. Yeung MC, Pulliam L, Lau A. The HIV envelope protein gp 120 is toxic to human brain culture through the induction of interleukin-6 and tumor necrosis factor-[alpha]. AIDS 1995, 9:137-143.
39. Philippon V. The basic domain of the lentivirus protein is responsible for damage in mouse brain: involvement of cytokines. Virology 1994, 205:519-529.
40. McKhann G, Drachman DA, Folstein MF, Katzman R, Price DL, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
41. Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC. Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J Neurovirol 2000, 6:84-88.
42. Dal Pan GJ, Farzadegan H, Selnes O, Hoover DR, Miller EN, Skolasky RL, et al. Sustained cognitive decline in HIV infection: relationship to CD4+ cell count, plasma viremia, and p24 antigenemia. J Neurovirol 1998, 4:95-99.
43. Childs EA, Lyles RH, Seines OA, Chen B, Miller EN, Cohen BA, et al. Plasma viral load and CD4 lymphocytes as predictive markers for HIV-associated dementia and sensory neuropathy. Neurology 1999, 52:607-613.
44. Sacktor N, Skolasky RL, Tarwater PM, McArthur JC, Selnes OA, Becker JT, et al. Response to systemic HIV viral load suppression correlates with psychomotor speed performance. Neurology 2003, 61:567-569.